Nature Publishing Group, publisher of Nature, and other science journals and reference works
Nature
my account e-alerts subscribe register
   
Tuesday 23 May 2017
Journal Home
Current Issue
AOP
Archive
Download PDF
References
Export citation
Export references
Send to a friend
More articles like this

Letters to Nature
Nature 345, 716 - 718 (21 June 1990); doi:10.1038/345716a0

Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala

Mindy J. D. Miserendino, Catherine B. Sananes, Kathleen R. Melia & Michael Davis

Yale University School of Medicine, Abraham Ribicoff Research Facilities of The Connecticut Mental Health Center, 34 Park Street, New Haven, Connecticut 06508, USA

RECEPTORS for N-methyl-D-aspartate (NMDA) seem to have a critical role in synaptic plasticity1–4. NMDA antagonists (such as AP5) prevent induction of long-term potentiation5,6, an activity-dependent enhancement of synaptic efficacy mediated by neural mechanisms that might also underlie learning and memory. They also attenuate memory formation in several behavioural tasks7–17; there are few data, however, implicating an NMDA-sensitive measure of conditioning based on local infusion of antagonists into a brain area tightly coupled to the behavioural response used to assess conditioning. We now show that NMDA antagonists infused into the amygdala block the acquisition, but not the expression, of fear conditioning measured with a behavioural assay mediated by a defined neural circuit (fear-potentiation of the acoustic startle reflex). This effect showed anatomical and pharmacological specificity, and was not attributable to reduced salience of the stimuli of light or shock used in training. The data indicate that an NMDA-dependent process in the amygdala subserves associative fear conditioning.

------------------

References

1. Collingridge, G. L. & Bliss, T. V. P. Trends Neurosci. 10, 288−293 (1987). | Article | ISI | ChemPort |
2. Artola, A. & Singer, W. Nature 330, 649−652 (1987). | Article | PubMed | ISI | ChemPort |
3. Cline, H. T., Debski, E. A. & Constantine-Patton, M. Proc. natn. Acad. Sci. U.S.A. 84, 4342−4345 (1987). | ChemPort |
4. Kleinschmidt, A. Bear, M. F. & Singer, W. Science 238, 355−358 (1987). | PubMed | ISI | ChemPort |
5. Collingridge, G. L., Kehl, S. J. & McLennan, H. J. Physiol., Lond. 334, 33−46 (1983). | PubMed | ISI | ChemPort |
6. Cotman, C. W., Monaghan, D. T. & Ganong, A. H. A. Rev. Neurosci. 11, 61−80 (1988). | ChemPort |
7. Morris, R. G. M., Anderson, E., Lynch, G. S. & Baudry, M. Nature 319, 774−776 (1986). | Article | PubMed | ISI | ChemPort |
8. Morris, R. G. M., J. Neurosci. 9, 3040−3057 (1989). | PubMed | ISI | ChemPort |
9. Benvenga, M. J. & Spaulding, T. C. Pharmacol. Biochem. Behav. 30, 205−207 (1988). | Article | PubMed | ChemPort |
10. Butelman, E. R., Pharmacol. Biochem. Behav. 34, 13−16 (1988).
11. Danysz, W. & Wroblewski, J. T. Neurosci. Res. Commun. 5, 9−18 (1989). | ChemPort |
12. Danysz, W., Wroblewski, J. T. & Costa, E. Neuropharmacology 27, 653−656 (1988). | Article | PubMed | ChemPort |
13. Staubli, U., Thibault, O., Lorenzo, M. & Lynch, G. S. Behav. Neurosci. 103, 54−60 (1989). | Article | PubMed | ISI | ChemPort |
14. Robinson, G. S., Crooks, G. B., Shinkman, P. G. & Gallagher, M. Psychobiology 17, 156−164 (1989). | ChemPort |
15. Tan, S., Kirk, R. C., Abraham, W. C., & McNaughton, N. Psychopharmacology 98, 556−560 (1989). | Article | PubMed | ChemPort |
16. Mondadori, C., Weiskrantz, L., Buerki, H., Petschke, F. & Fagg, G. E. Exp Brain Res. 75, 449−456 (1989) | PubMed | ISI | ChemPort |
17. Hauber, W. & Schmidt, W. J. J. neural Transm. 78, 29−41 (1989) | Article | ChemPort |
18. Davis, M., Gendelman, D. S., Tischler, M. D. & Gendelman, P. M. J. Neurosci. 2, 791−805 (1982). | PubMed | ISI | ChemPort |
19. Rosen, J. B., Hitchcock, J. M., Sananes, C. B., Miserendino, M. J. D. & Davis, M. Behav. Neurosci. (in the press).
20. Hitchcock, J. M. & Davis, M. Behav. Neurosci. 100, 11−22 (1986). | Article | PubMed | ISI | ChemPort |
21. Hitchcock, J. M., Sananes, C. B. & Davis, M. Behav. Neurosci. 103, 509−518 (1989). | Article | PubMed | ChemPort |
22. Rosen, J. B. & Davis, M. Behav. Neurosci. 102, 195−202 (1988). | PubMed | ChemPort |
23. Cotman, C. W., Monaghan, D. T., Otterson, O. P. & Storm-Mathisen, J. Trends Neurosci. 10, 273−280 (1987). | Article | ChemPort |
24. Thompson, R. F. et al., in Classical Conditioning III. Behavioral, Neurophysiological and Neurochemical Studies in the Rabbit (eds Gormezano, I. Prokasy, W. F. & Thompson, R. F.) (Erlbaum, Hillsdale, New Jersey, 1987).
25. Liang, K. C., Juler, R. G. & McGaugh, J. L. Brain Res. 368, 125−133 (1986). | Article | PubMed | ChemPort |
26. Weiner, N. in The Pharmacological Basis of Therapeutics (eds Gilman, A. G., Goodman, L. S., Rall, T. W. & Murad, F.) (Macmillan, New York, 1985).
27. Chapman, P. F. & Brown, T. H. Soc. Neurosci. Abstr. 14, 566 (1988).
28. Cassella, J. V. & Davis, M. Physiol. Behav. 36, 377−383 (1986). | Article | PubMed | ISI | ChemPort |
29. Kehne, J. H. Cassella, J. V. & Davis, M. Psychopharmacology 94, 8−13 (1988). | Article | PubMed | ISI | ChemPort |



© 1990 Nature Publishing Group
Privacy Policy